From RD to Commercialization: Tackling the Challenges of ОРД Process Scale-Up

Oral dissolvable films (ODFs) have emerged as an innovative dosage form, but moving from лаб-scale R&D to commercial-scale production requires overcoming significant hurdles. Ensuring process consistency and данные comparability across each stage is one of the biggest challenges for regulatory approval and market entry.

Why Is Process Scale-Up So Challenging?

• оборудование differences: лаб models and commercial-scale машины vary greatly, making данные hard to compare.
• Parameter inconsistency: покрытие thickness, drying conditions, and cutting methods may differ between systems.
• Regulatory требования: Drug registration demands proof of process continuity and stability; gaps can lead to revalidation or even failure.

Common Industry Pain Points

• Repeated validation: лаб-scale данные is often not accepted, forcing revalidation at pilot and commercial stages.
• Increased cost and timelines: Repeated trials extend development cycles and raise costs.
• Process risks: плёнка quality may become unstable after scale-up, resulting in batch rejections.

HUANGHAI’s Solutions

• Consistent process design: Whether using the MJ150-L or MJ150, the покрытие and drying logic remains the same, ensuring данные comparability.
• Pilot-scale bridge: The MJ150-L acts as a pilot unit, creating a smooth transition between лаб research and full-scale production.
• Modular scalability: With modular upgrades, companies can quickly move from R&D to commercial output without starting over.
• End-stage integration: The MJF180 cutting & packaging машина ensures accurate dosing and stable packaging for compliant ОРД products.

соответствие and Quality Value

• Improves данные continuity to support drug registration and GMP audits.
• Reduces risk from process discrepancies.
• Accelerates time-to-market, increasing commercialization success rates.

Recommended оборудование

• MJ150-L Pilot/Research покрытие машина
• MJ150 Commercial покрытие машина
• MJF180 ОРД Cutting & Packaging машина

Conclusion

ОРД process scale-up is more than just expanding capacity — it is about maintaining consistency, соответствие, and product stability. With unified process design and modular production lines, HUANGHAI helps clients transition smoothly from R&D to commercialization, minimizing risks and accelerating market entry.

*Features Huanghai's exclusive patented hot-air drying technology (Patent No. CN201668734U) ensuring uniform bottom-up heating.

---

Frequently Asked Questions

Q: What is the difference between an ОРД плёнка and a трансдермальный пластырь?

A: Oral Dissolving Films (ОРД) are placed on or under the tongue and dissolve within seconds to minutes, delivering APIs directly through the oral mucosa or via swallowing. Transdermal patches adhere to the skin and deliver APIs through the dermal layers into systemic circulation over hours to days. Despite different delivery routes, both are manufactured using similar растворитель-cast плёнка покрытие processes. Huanghai's MJ150 ОРД машина supports both applications on a single platform with approximately 2 working days of changeover time.

Q: What production output can I expect from a Huanghai ОРД машина?

A: The MJ150 produces 20,000 films/hour at commercial scale. The MJ150-L targets R&D and pilot production at 8,000–10,000 films/hour. For fully integrated lines, pair either машина with the MJF180 automatic cutting and packaging system (11,900 films/hr) or the more affordable EZ320 (9,000 films/hr). A complete MJ150 + MJF180 line can produce over 150 million finished pouches annually on a single-shift basis. Contact us for pricing and configuration details.

Q: What drying technology does Huanghai use for ОРД production?

A: Huanghai uses patented gradient hot-air drying (Patent CN201668734U), which applies a smooth progressive temperature drop rather than stepwise oven zones used by competitors. This results in more uniform плёнка thickness, reduced edge curl, and better АФИ distribution across the плёнка web. An optional far-infrared heating module adds 20–30% drying efficiency for растворитель-based formulations. This patented drying system is one of the key technical advantages that justifies Huanghai's position as the preferred ОРД оборудование supplier to Sinopharm, Shanghai фарма, and Fosun фарма.

Q: What are the GMP требования for ОРД production оборудование?

A: ОРД производство оборудование must comply with cGMP (21 CFR Parts 210/211) for US market products, and equivalent стандарты (EU GMP Annex 1, ChGMP) for other markets. Key требования: material contact surfaces must be 316L stainless steel or equivalent; CIP/SIP capability or documented cleaning validation; данные integrity controls meeting ALCOA+ principles (audit trails, access control). Huanghai ОРД машины meet these стандарты—all product contact surfaces use фармацевтический-grade materials, and the control system includes operator access logs and parameter change records. Request our GMP соответствие documentation.

Q: Can Huanghai машины produce stripe-coated or multi-formula ОРД films?

A: Yes. Huanghai holds a patent for multi-formula stripe покрытие (Patent CN117323228A), enabling two different АФИ formulations to be applied side-by-side in a single покрытие pass. This eliminates the need for multiple покрытие/drying cycles when producing combination-drug ОРД products. Competitors require manual multi-layer покрытие with drying intervals between each formula. This capability is particularly valuable for fixed-dose combination products (e.g., dual-АФИ ODFs for cardiovascular or CNS indications) where покрытие efficiency directly impacts production economics.